Please select and order
€120.67
excl. VAT
CONFIGURE NOW
Norm

ÖNORM EN ISO 18362

Issue date: 2018 11 15

Manufacture of cell-based health care products - Control of microbial risks during processing (ISO 18362:2016)

This International Standard specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products ...
Read more
Valid
Publisher:
Austrian Standards International
Format:
Digital | 48 Pages
Language:
German | English | Download GER/ENG
This International Standard specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled ‘sterile’ and to CBHPs not labelled ‘sterile’. This International Standard is not applicable to: — procurement and transport of cell-based starting material used in processing of a CBHP, — cell banking, — control of genetic material, — control of non-microbial product contamination, — in vitro diagnostics (IVDs), or — natural medicines. This International Standard does not define biosafety containment requirements. This International Standard does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.